$FB Investor Business Daily : Facebook Price Targets Raised After ‘Blowout’ Q4 Earnings
users liked this posts
users disliked this posts
Reuters-- Facebook's market value surges $38 billion as mobile ad sales soar LINK
Titan Pharma and Braeburn Pharmaceuticals receive FDA recommendation for Probuphine (TTNP) :
Titan Pharmaceuticals and partner Braeburn Pharmaceuticals announced that the Psychopharmacologic Drugs Advisory Committee of the FDA voted in favor of approving Probuphine, the first long-acting,subdermal buprenorphine implant for the maintenance treatment of opioid, painkiller addiction and relapse patients
EMQ News & Analysis
Celgene Co. (CELG) Shares Bought by EQIS Capital Management
By Brady Heezen on Jan 9th, 2016 // No Comments
Celgene logoEQIS Capital Management boosted its stake in Celgene Co. (NASDAQ:CELG) by667.7%during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Love the writer of the article, always gets it right.
Tepper and Morgan checked books, Tepper wants cheap shares to add to fund, he knows books are good.
wall street corrupt
Correct, They Know How to check it better than anyone. Not going to invest their money unless it checks out.